JP2009512706A5 - - Google Patents

Download PDF

Info

Publication number
JP2009512706A5
JP2009512706A5 JP2008536755A JP2008536755A JP2009512706A5 JP 2009512706 A5 JP2009512706 A5 JP 2009512706A5 JP 2008536755 A JP2008536755 A JP 2008536755A JP 2008536755 A JP2008536755 A JP 2008536755A JP 2009512706 A5 JP2009512706 A5 JP 2009512706A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
independently
heterocyclyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008536755A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009512706A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/040664 external-priority patent/WO2007050380A2/en
Publication of JP2009512706A publication Critical patent/JP2009512706A/ja
Publication of JP2009512706A5 publication Critical patent/JP2009512706A5/ja
Withdrawn legal-status Critical Current

Links

JP2008536755A 2005-10-21 2006-10-18 チロシンキナーゼインヒビター Withdrawn JP2009512706A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72899705P 2005-10-21 2005-10-21
PCT/US2006/040664 WO2007050380A2 (en) 2005-10-21 2006-10-18 Tyrosine kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2009512706A JP2009512706A (ja) 2009-03-26
JP2009512706A5 true JP2009512706A5 (cg-RX-API-DMAC7.html) 2009-12-03

Family

ID=37968376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008536755A Withdrawn JP2009512706A (ja) 2005-10-21 2006-10-18 チロシンキナーゼインヒビター

Country Status (6)

Country Link
US (1) US7790739B2 (cg-RX-API-DMAC7.html)
EP (1) EP1951047A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009512706A (cg-RX-API-DMAC7.html)
AU (1) AU2006306496A1 (cg-RX-API-DMAC7.html)
CA (1) CA2624676A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007050380A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2408584C2 (ru) 2005-06-23 2011-01-10 Мерк Шарп Энд Домэ Корп. Ингибиторы тирозинкиназы
US7893081B2 (en) 2007-12-20 2011-02-22 Merck & Co., Inc. Tyrosine kinase inhibitors
US9238571B2 (en) 2009-09-30 2016-01-19 Merck Sharp & Dohme Limited Formulations for c-Met kinase inhibitors
WO2011049625A1 (en) 2009-10-20 2011-04-28 Mansour Samadpour Method for aflatoxin screening of products
LT2496567T (lt) 2009-11-05 2017-11-27 Rhizen Pharmaceuticals S.A. Nauji benzopirano kinazės moduliatoriai
PT2705029T (pt) 2011-05-04 2019-02-01 Rhizen Pharmaceuticals S A Novos compostos como moduladores de proteína quinases
PT2870157T (pt) 2012-07-04 2017-11-27 Rhizen Pharmaceuticals S A Inibidores seletivos de delta pi3k
US10086000B2 (en) 2014-12-05 2018-10-02 Merck Sharp & Dohme Corp. Tricyclic compounds as inhibitors of mutant IDH enzymes
WO2016089830A1 (en) 2014-12-05 2016-06-09 Merck Sharp & Dohme Corp. Novel tricyclic compounds as inhibitors of mutant idh enzymes
US10442819B2 (en) 2014-12-05 2019-10-15 Merck Sharp & Dohme Corp. Tricyclic compounds as inhibitors of mutant IDH enzymes
CN116410211A (zh) * 2021-12-29 2023-07-11 山东新时代药业有限公司 一种苯并呋喃类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
AU700386B2 (en) 1995-10-16 1999-01-07 Kyowa Hakko Kogyo Co. Ltd. Triciclic compounds
CA2460939C (en) 2001-09-19 2008-07-29 Pharmacia Corporation Substituted pyrazolyl compounds for the treatment of inflammation
AU2003230758A1 (en) 2002-04-02 2003-10-20 Merck And Co., Inc. 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
RU2408584C2 (ru) 2005-06-23 2011-01-10 Мерк Шарп Энд Домэ Корп. Ингибиторы тирозинкиназы
AU2006306499A1 (en) 2005-10-21 2007-05-03 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
AU2006306517A1 (en) 2005-10-21 2007-05-03 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2008505167A5 (cg-RX-API-DMAC7.html)
CN107548391A (zh) 嘧啶或吡啶类化合物、其制备方法和医药用途
CN107250130B (zh) 杂环化合物及包含其的药物组合物
JP2016523973A5 (cg-RX-API-DMAC7.html)
JP2022516883A5 (cg-RX-API-DMAC7.html)
JP2008538750A5 (cg-RX-API-DMAC7.html)
JP2014514317A5 (cg-RX-API-DMAC7.html)
JP2011522889A5 (cg-RX-API-DMAC7.html)
RU2012131124A (ru) Птеридиноны как ингибиторы polo-подобных киназ
JP2020517616A5 (cg-RX-API-DMAC7.html)
JP2013544847A5 (cg-RX-API-DMAC7.html)
JP2008156336A5 (cg-RX-API-DMAC7.html)
JP2020012001A (ja) Tam rtkインヒビターとしてのキノリン誘導体
JP2008528467A5 (cg-RX-API-DMAC7.html)
JP2014525432A5 (cg-RX-API-DMAC7.html)
JP2008525417A5 (cg-RX-API-DMAC7.html)
JP2010523670A5 (cg-RX-API-DMAC7.html)
JP2018525375A5 (cg-RX-API-DMAC7.html)
JP2017533932A (ja) タンパク質キナーゼ阻害剤としての6−アミノ−7−ビシクロ−7−デアザ−プリン誘導体
RU2006131591A (ru) Способ получения 2-аминотиазол-5-ароматических карбоксамидов в качестве ингибиторов киназ
JP2015523383A5 (cg-RX-API-DMAC7.html)
HRP20221090T1 (hr) Određeni triazolopirazini, njihovi pripravci i postupci njihove upotrebe
RU2015143717A (ru) 2-Аминопиримидин-6-оны и аналоги, проявляющие противораковые и антипролиферативные действия
RU2009146832A (ru) Производные хиназолиноксима в качестве ингибиторов hsp90
WO2016006706A1 (ja) テトラヒドロピラ二ルメチル基を有するピリドン誘導体